文献速递主动脉疾病

小腹主动脉瘤患者心血管事件风险显著且未被充分管理

Patients with Small Abdominal Aortic Aneurysm are at Significant Risk of Cardiovascular Events and this Risk is not Addressed Sufficiently.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2016-11-22

研究基于英国腹主动脉瘤生长研究(UKAGS)384例小腹主动脉瘤(AAA,直径<55 mm)男性及142例本地队列患者,评估其心血管(CV)风险特征。结果显示多数患者吸烟、高血压和高胆固醇血症患病率高,进入AAA监测后未更易接受CV药物,且全部本地患者Framingham、JBS-2和ASSIGN评分均属高风险,1年内收缩压无变化而胆固醇升高。结论认为小AAA患者CV风险显著且未被充分处理,需设计针对性CV风险降低方案。

要点

  • 小AAA患者心血管风险高,但监测期间CV药物使用未增加。
  • 全部本地患者Framingham、JBS-2和ASSIGN评分均属高风险。
  • 1年内收缩压无变化,胆固醇从4.0 mmol升至4.2 mmol。

核心结论

  • 小AAA患者心血管事件风险显著,且当前未被充分处理。

研究设计与样本

  • 评估384例UKAGS小AAA(<55 mm)男性及142例本地小AAA患者血压和血脂谱的前瞻性队列。

主要发现

  • UKAGS人群54%现吸烟、30%曾吸烟,58%高血压,54%高胆固醇血症。
  • 本地组54%现吸烟、40%曾吸烟,94%高血压。
  • 两组进入AAA监测后接受CV药物的可能性未增加。
  • 本地患者Framingham评分均值21.8%(95%CI 20.0-23.6),JBS-2 16.3%(14.7-17.9),ASSIGN 25.2%(22.7-27.7)。
  • 1年收缩压无变化(140.9 mmHg vs 142.5 mmHg,p=.435),胆固醇升高(4.0 mmol-4.2 mmol,p<.0001)。

临床怎么用

  • 对进入AAA监测的小AAA患者应主动评估和管理心血管风险。
  • 需设计并实施针对该人群的CV风险降低方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with abdominal aortic aneurysm (AAA) are at significant risk of cardiovascular (CV) events. Recent implementation of AAA-screening means thousands of patients are now diagnosed with small-AAA; however, CV risk factors are not always addressed. This study aimed at assessing and quantifying the CV characteristics of patients with small AAA following the introduction of screening programmes. METHODS: CV profiles of 384 men with a small AAA (<55 mm diameter) were assessed through the United Kingdom Aneurysm Growth Study (UKAGS), a nationwide prospective cohort study of men with small AAA. A prospective local cohort of an additional 142 patients with small AAA with available blood pressure (BP) and lipid profiles was also included and followed-up for 1 year. RESULTS: In the UKAGS population, 54% were current and 30% ex-smokers; 58% were hypertensive and 54% hypercholesterolaemic. In the local group, 54% were current and 40% were ex-smokers, and 94% were hypertensive. Patients were not more likely to receive CV medication after entering AAA surveillance in either group. All local patients were clustered "high-risk" for future CV events based on the Framingham score (mean 21.8%, 95% CI 20.0-23.6), JBS-2 (16.3%, 14.7-17.9) and ASSIGN (25.2%, 22.7-27.7). No change was seen in systolic BP levels between baseline and 1 year (140.9 mmHg vs. 142.5 mmHg, p=.435). A rise was seen in cholesterol (4.0 mmol-4.2 mmol, p<.0001) values at 1 year. CONCLUSIONS: This study suggests that patients with small AAA are at significant risk for developing CV events and this is not currently addressed, which is evident by the "high-risk" CV risk profiles of these patients despite being in AAA surveillance. Design and implementation of a CV risk reduction programme tailored for this population is necessary.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Bath MF, Saratzis A, Saedon M, et al. Patients with Small Abdominal Aortic Aneurysm are at Significant Risk of Cardiovascular Events and this Risk is not Addressed Sufficiently. Eur J Vasc Endovasc Surg. 2016. PMID: 27884711. doi:10.1016/j.ejvs.2016.10.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。